symbiotec phamralab ipo review & analysis: gmp, financials & retail strategy
Pharma sector ki leader Symbiotec Pharmalab apna ₹1,757 Cr ka IPO laa rahi hai. Janiye current GMP (27%), financials, risks aur retailer recommendation hamari is deep analysis mein.
Symbiotec Pharmalab IPO Review: Pharma Sector Ka Naya Multi-Bagger Ya Bada Risk? (Deep Analysis)
Dosto, kya aap jante hain ki duniya bhar mein jo life-saving dawaian aur hormonal treatments use hote hain, unka "raw...
